SOAR Corp is a Medication Assisted Treatment program committed to helping individuals overcome the devastating impact of addiction. The management, administrative, clinical, and medical staff are committed to providing the highest level of services to all clients based on their assessed treatment needs. All clients will be required to sign a Treatment Agreement at the time of admission.
- All new admission will be required to attend the Orientation /Methadone Safety group 2 times in the first 30 days of treatment.
- All patients in the Out-Patient Level of care shall attend a minimum of 1 individual session and 1 three-hour group per week throughout their course of treatment.
- All Intensive Outpatient Patients shall attend a minimum of 1 individual session and 3 group sessions per week during the IOP placement.
- All patients must attend their schedule medical appointments, medication reviews and annual physical as the appointments are scheduled. Failure to attend these appointments can result a medication order becoming expired and delays in the ability to dispense your medication daily.
- All new admission will have completed any requested PPD, blood work or other requested medical testing in the first 30 days of treatment.
- All patients shall provide urine drug screens when requested. Any failure to or refusal to complete this action shall result in the patient forfeiting their schedule daily dose of medication.
- All payments with cost associated with treatment (i.e. co-payments and cost share) shall establish a therputice agreement at admission and update as statuses change. Failure to remin compliant with the theraputice agreement may result in a transfer or MSW from the program
- For effective treatment outcomes, all patients are expected to receive their schedule dose of medication daily from Soar. However, for safety issues, if impairment is observed, Soar may elect to not give the patient their daily dose of medication. If a patient is denied dosing due to impairment, they will be asked to come back the next day for assessment and dosing.